Ausgabe 2/2000
Inhalt (14 Artikel)
Open Access
Review
Low-molecular-weight heparins in the treatment of venous thromboembolism
Walter Ageno, Menno V Huisman
Open Access
Commentary
Debate: Are surrogate end-point studies worth the effort?
Jonathan Valabhji, Robert S Elkeles
Open Access
Commentary
Angiotensin receptor blockers in heart failure after the ELITE II trial
Ronnie Willenheimer
Open Access
Commentary
Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
Peter B Berger
Open Access
Commentary
Clinical applicability of molecular biology: the case of the long QT syndrome
Peter J Schwartz
Open Access
Commentary
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
Jacobus Lubsen
Open Access
Commentary
Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
Sidney Goldstein
Open Access
Commentary
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
Henry H Hsia, Mariell L Jessup, Francis E Marchlinski
Open Access
Review
Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy
Hubert Seggewiss